{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:11:08Z","timestamp":1792948268887,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.apsb.2024.06.013","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:42:02Z","timestamp":1718901722000},"page":"4345-4359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the \u03c31 chaperone protein"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-3132","authenticated-orcid":false,"given":"Laura","family":"Garc\u00eda-Pupo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Crouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-3751","authenticated-orcid":false,"given":"Alberto","family":"Bencomo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Morilleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-6923","authenticated-orcid":false,"given":"Benjamin","family":"Delprat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-8302","authenticated-orcid":false,"given":"Marquiza Sabl\u00f3n","family":"Carrazana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Men\u00e9ndez Soto del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4074-6793","authenticated-orcid":false,"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3958-183X","authenticated-orcid":false,"given":"Chryslaine","family":"Rodr\u00edguez-Tanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.06.013_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12035-010-8137-1","article-title":"Why pleiotropic interventions are needed for Alzheimer's disease","volume":"41","author":"Frautschy","year":"2010","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2024.06.013_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14336\/AD.2021.0529","article-title":"The cause of Alzheimer's disease: the theory of multipathology convergence to chronic neuronal stress","volume":"13","author":"Decourt","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2024.06.013_bib3","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.013_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.06.013_bib5","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1073\/pnas.1300677110","article-title":"Modulation of the endoplasmic reticulum\u2013mitochondria interface in Alzheimer's disease and related models","volume":"110","author":"Hedskog","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.013_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105020","article-title":"Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain","volume":"143","author":"Lau","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2024.06.013_bib7","first-page":"788","article-title":"Ca2+ signaling via sigma1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration","volume":"293","author":"Hayashi","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2024.06.013_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.06.013_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fphar.2019.00223","article-title":"Allosteric modulators of sigma-1 receptor: a review","volume":"10","author":"Vavers","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/17460441.2021.1838483","article-title":"Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders","volume":"16","author":"Maurice","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.apsb.2024.06.013_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/164_2017_15","article-title":"Sigma-1 (\u03c31) receptor in memory and neurodegenerative diseases","volume":"244","author":"Maurice","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115700","article-title":"A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease","volume":"28","author":"Rivera-Marrero","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1874471012666190102165053","article-title":"[18F]Amylovis as a potential pet probe for \u03b2-amyloid plaque: synthesis, in silico, in\u00a0vitro and in\u00a0vivo evaluations","volume":"12","author":"Rivera-Marrero","year":"2019","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.apsb.2024.06.013_bib14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/jm00034a020","article-title":"Structural features important for sigma1 receptor binding","volume":"37","author":"Glennon","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib16","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/cr00023a012","article-title":"From atoms and bonds to three-dimensional atomic coordinates: automatic model builders","volume":"93","author":"Sadowski","year":"1993","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.06.013_bib17","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminform"},{"key":"10.1016\/j.apsb.2024.06.013_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<616::AID-JCC5>3.0.CO;2-X","article-title":"Extension of MMFF94 using experimental data, additional computational data, and empirical rules","volume":"17","author":"Halgren","year":"1996","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2024.06.013_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.apsb.2024.06.013_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh3763","article-title":"Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models","volume":"14","author":"Crouzier","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2024.06.013_bib23","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs Reporting Guidelines Working Group. Animal research: reporting in\u00a0vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered \u03b2-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2024.06.013_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2024.06.013_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0091-3057(94)90235-6","article-title":"PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice","volume":"49","author":"Maurice","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.apsb.2024.06.013_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid \u03b225\u201335 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphar.2019.00519","article-title":"A new pharmacophore model for the design of sigma-1 ligands validated on a large experimental dataset","volume":"10","author":"Pascual","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.06.013_bib30","doi-asserted-by":"crossref","first-page":"20333","DOI":"10.1074\/jbc.M113.537993","article-title":"The oligomeric states of the purified sigma-1 receptor are stabilized by ligands","volume":"289","author":"Gromek","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib31","doi-asserted-by":"crossref","first-page":"14997","DOI":"10.1021\/acs.jmedchem.1c00886","article-title":"Bitopic sigma1 receptor modulators to shed light on molecular mechanisms underpinning ligand binding and receptor oligomerization","volume":"64","author":"Rossino","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41594-018-0137-2","article-title":"Structural basis for \u03c31 receptor ligand recognition","volume":"25","author":"Schmidt","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.apsb.2024.06.013_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF02249345","article-title":"Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice","volume":"114","author":"Maurice","year":"1994","journal-title":"Psychopharmacol Berl"},{"key":"10.1016\/j.apsb.2024.06.013_bib34","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/npp.2008.212","article-title":"Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid \u03b225\u201335-induced toxicity in mice","volume":"34","author":"Villard","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apsb.2024.06.013_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02740836","article-title":"A potential role for apoptosis in neurodegeneration and Alzheimer's disease","volume":"10","author":"Cotman","year":"1995","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2024.06.013_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejmech.2018.10.064","article-title":"Novel multitarget-directed ligands targeting acetylcholinesterase and \u03c31 receptors as lead compounds for treatment of Alzheimer's disease: synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase","volume":"162","author":"Lalut","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib37","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jmedchem.1c00534","article-title":"Selective pseudo-irreversible butyrylcholinesterase inhibitors transferring antioxidant moieties to the enzyme show pronounced neuroprotective efficacy in\u00a0vitro and in\u00a0vivo in an Alzheimer's disease mouse model","volume":"64","author":"Scheiner","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib38","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2174\/1567205014666170508121031","article-title":"Nanotechnology based theranostic approaches in Alzheimer's disease management: current status and future perspective","volume":"14","author":"Ahmad","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.apsb.2024.06.013_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1381612827666211122153946","article-title":"Theranostic applications of nanomaterials in Alzheimer's disease: a multifunctional approach","volume":"28","author":"Tripathi","year":"2022","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2024.06.013_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/molecules23030686","article-title":"Diabetes drug discovery: hIAPP1-37 polymorphic amyloid structures as novel therapeutic targets","volume":"23","author":"Fern\u00e1ndez-G\u00f3mez","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2024.06.013_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135292","article-title":"Drug development in conformational diseases: a novel family of chemical chaperones that bind and stabilise several polymorphic amyloid structures","volume":"10","author":"Sabl\u00f3n-Carrazana","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2024.06.013_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148848","article-title":"Amylovis-201 enhances physiological memory formation and rescues memory and hippocampal cell loss in a streptozotocin-induced Alzheimer's disease animal model","volume":"1831","author":"Mercer\u00f3n-Mart\u00ednez","year":"2024","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2024.06.013_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.103.051284","article-title":"Sigma-1 receptors (\u03c31 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export","volume":"306","author":"Hayashi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2024.06.013_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-319-50174-1_9","article-title":"Sigma-1 receptor antagonists: a new class of neuromodulatory analgesics","volume":"964","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.apsb.2024.06.013_bib45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2024.06.013_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The sigma-1 receptor as a pluripotent modulator in living systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2024.06.013_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10571-020-00983-3","article-title":"Knocking out sigma-1 receptors reveals diverse health problems","volume":"42","author":"Couly","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.apsb.2024.06.013_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","article-title":"The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus","volume":"578","author":"Martina","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2024.06.013_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061245","article-title":"Cocaine inhibits dopamine D2 receptor signaling via sigma-1\u2013D2 receptor heteromers","volume":"8","author":"Navarro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2024.06.013_bib50","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/s41467-020-19396-3","article-title":"Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS\/FTD models","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.06.013_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/15548627.2022.2063003","article-title":"Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1\/sigma-1 receptor chaperone by pridopidine","volume":"19","author":"Wang","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2024.06.013_bib52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/ml2001505","article-title":"Homology model and docking-based virtual screening for ligands of the \u03c31 receptor","volume":"2","author":"Laurini","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2024.06.013_bib53","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.bmcl.2012.08.046","article-title":"A \u03c31 receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)] dodecan-3-ols (AHDs)","volume":"22","author":"Banister","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2024.06.013_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmgm.2003.08.001","article-title":"Molecular modeling of sigma1 receptor ligands: a model of binding conformational and electrostatic considerations","volume":"22","author":"Gund","year":"2004","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.apsb.2024.06.013_bib55","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1021\/jm049073+","article-title":"Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening","volume":"48","author":"Laggner","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib56","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.ejmech.2010.03.048","article-title":"5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling","volume":"45","author":"Oberdorf","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib57","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/jm900366z","article-title":"Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives","volume":"52","author":"Zampieri","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.013_bib58","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.109.160960","article-title":"Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor \u03baB","volume":"332","author":"Meunier","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2024.06.013_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)83020-8","article-title":"SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice","volume":"328","author":"Maurice","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","article-title":"Sigma1 (\u03c31) receptor agonists and neurosteroids attenuate \u03b225\u201335-amyloid peptide-induced amnesia in mice through a common mechanism","volume":"83","author":"Maurice","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2024.06.013_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems","volume":"240","author":"Su","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.06.013_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94079-7","article-title":"Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy","volume":"11","author":"Reyes","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2024.06.013_bib63","first-page":"543","article-title":"Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand","volume":"259","author":"Su","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2024.06.013_bib64","first-page":"123","article-title":"In\u00a0vivo electrophysiological evidence for a selective modulation of N-methyl-d-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands","volume":"261","author":"Monnet","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2024.06.013_bib65","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0269881110379286","article-title":"Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor\/sigma1 (\u03c31) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative","volume":"25","author":"Villard","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.apsb.2024.06.013_bib66","first-page":"463","article-title":"Mitochondrial protection by the mixed muscarinic\/\u03c31 ligand ANAVEX2-73, a tetrahydrofuran derivative, in A\u03b225\u201335 peptide-injected mice, a nontransgenic Alzheimer's disease model","volume":"8","author":"Lahmy","year":"2015","journal-title":"Front Cel Neurosci"},{"key":"10.1016\/j.apsb.2024.06.013_bib67","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau hyperphosphorylation and A\u03b21\u201342 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c3\u2081 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apsb.2024.06.013_bib68","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-200508010-00018","article-title":"Neuroprotective effects of sigma-1 receptor agonists against \u03b2-amyloid-induced toxicity","volume":"16","author":"Marrazzo","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.apsb.2024.06.013_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-017-9838-2","article-title":"Sigma-1 receptor agonists induce oxidative stress in mitochondria and enhance complex I activity in physiological condition but protect against pathological oxidative stress","volume":"35","author":"Goguadze","year":"2019","journal-title":"Neurotox Res"},{"key":"10.1016\/j.apsb.2024.06.013_bib70","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2024.06.013_bib71","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nn.4025","article-title":"Central role for PICALM in amyloid-\u03b2 blood\u2013brain barrier transcytosis and clearance","volume":"18","author":"Zhao","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2024.06.013_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-3-319-50174-1_2","article-title":"Structural perspectives on sigma-1 receptor function","volume":"964","author":"Alon","year":"2017","journal-title":"Adv Exp Med Biol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:10:19Z","timestamp":1729696219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2211383524002442"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.06.013","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the \u03c31 chaperone protein","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}